Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present VMS Rehab Systems Inc. (OTC: VRSYF).

Full DD Report for VRSYF

You must become a subscriber to view this report.


Recent News from (OTC: VRSYF)

VMS Rehab Systems, Inc. (VRSYF) launches new Poland unit
VMS Rehab Systems, Inc. (VRSYF) launches new Poland unit
Source: OTC Markets
Date: December, 28 2017 00:00
Argus Worldwide Corp. acquires control block of early stage generic pharmaceutical firm BioPharmcor BV
Argus Worldwide Corp. acquires control block of early stage generic pharmaceutical firm BioPharmcor BV
Source: OTC Markets
Date: October, 19 2017 00:00
VMS Rehab Systems, Inc. confirms plans to acquire Interactive Health Systems, Inc.
OTTAWA, Ontario , Nov. 22, 2016 /PRNewswire/ -- VMS Rehab Systems, Inc. reported today that the Company intends to complete the acquisition of Interactive Health Systems. Inc., a privately held US Corporation headquartered in Cheyenne, Wyoming . The all stock transaction is schedule...
Source: PR Newswire
Date: November, 22 2016 13:50
VMS Rehab Systems, Inc. generic drug unit signs Memorandum of Understanding to fund new Corporate Bond Issue
OTTAWA, Ontario , Oct. 24, 2016 /PRNewswire/ -- VMS Rehab Systems, Inc. reported today that BioPharmcor Sp z o.o., the Poland based subsidiary of its generic drug company, BioPharmcor B.V., has signed a Memorandum of Understanding with a private investor to acquire up to 4.5 millio...
Source: PR Newswire
Date: October, 24 2016 11:13
VMS Rehab Systems announces postponement of Annual General Meeting
VMS Rehab Systems announces postponement of Annual General Meeting
Source: OTC Markets
Date: October, 10 2016 00:00
VMS Rehab Systems announces Annual General Meeting
VMS Rehab Systems announces Annual General Meeting
Source: OTC Markets
Date: September, 30 2016 00:00
VMS Rehab Systems, Inc. reports on status of its BioPharmcor drug unit formulation development program
OTTAWA, Ontario , Sept. 6, 2016 /PRNewswire/ -- The Board of Directors of VMS Rehab Systems, Inc. reported today that the Company's generic drug unit, BioPharmcor BV has made significant progress over the past 18 months in its formulation development program of its first generic drug...
Source: PR Newswire
Date: September, 06 2016 06:00
VMS Rehab Systems, Inc. set to launch investment strategy in E-Health
OTTAWA, Ontario , Aug. 29, 2016 /PRNewswire/ -- VMS Rehab Systems, Inc. reported today that it will launch an initiative to invest in the burgeoning E-Health segment of the Health Industry as early as the 4 th quarter of 2016. The Company has indicated that the proposed transaction ...
Source: PR Newswire
Date: August, 29 2016 04:00
VMS Rehab Systems, Inc. offers guidance on BioPharmcor generic drug unit
OTTAWA, Ontario , July 6, 2016 /PRNewswire/ -- In advance of European investor meetings for its Dutch based BioPharmcor BV generic drug unit, VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) is providing guidance on forecasted revenues and product development expen...
Source: PR Newswire
Date: July, 06 2016 02:00
VMS Rehab Systems, Inc. Eyes Anomaly in Stock Price
OTTAWA, Ontario , June 27, 2016 /PRNewswire/ -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today that the Company's Board will take whatever measures required to build a strong and stable market for trading in the Company's stock which is currently listed on the ...
Source: PR Newswire
Date: June, 27 2016 02:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-17N/A0.006N/AN/A0
2018-08-160.0060.0060.0060.00612,000
2018-08-15N/A0.007N/AN/A0
2018-08-14N/A0.007N/AN/A0
2018-08-13N/A0.007N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-095005,5009.0909Cover
2018-08-0146650093.2000Short
2018-07-30304,342304,342100.0000Short
2018-07-23800800100.0000Short
2018-07-094,00010,60037.7358Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on VRSYF.


About VMS Rehab Systems Inc. (OTC: VRSYF)

Logo for VMS Rehab Systems Inc. (OTC: VRSYF)

A provider of quality of life products for the home healthcare and wellness sectors

 

 

 

Current Management

  • Michael S. Wexler / CEO
    • Founded VMS Rehab Systems Inc in . Mr. Wexler has over years of knowhow and hands on management experience in the health industries. Negotiated the company s agreement as a core vendor of orthopedic seat cushions with Shoppers Drug Mart, Canada s largest home health and drug store retailer. More recently, Mr Wexler initiated an aggressive development and expansion program to broaden VMS market penetration in major global markets. An astute entrepreneur with over decades of hands on experience working with companies situated in North America and abroad, Mr. Wexler holds senior management positions and Board positions with companies in both the private and public sectors. An alumni of both Carleton University and the University of Ottawa, Mr. Wexler is a life member of the Rideau Club, Ottawa, Canada.
  • Frederick C. Bauman / Corporate Counsel
    • Fred Bauman is a Corporate, Securities and Mining attorney. A Harvard Law School graduate, Mr. Bauman has been based in Las Vegas, Nevada since . Prior to forming Bauman amp Associates, Mr. Bauman was Vice President and General Counsel of Sunterra, an international public resort company headquartered in Las Vegas . He was a previously a Corporate and Securities Partner at Brown amp Bain, a large Phoenixbased law firm with a high tech legal practice. Mr. Bauman joined Bell Atlantic now named Verizon in the s as a securities attorney, then served as general counsel of Bell Atlantic s computer business and, later, its financial services business. After graduating from Harvard Law School, he worked on Wall Street for six years, starting his legal career at Davis Polk, a large Wall Street law firm in New York City.
  • Carol D. Segal / NonExecutive Director
  • Michael S. Wexler /
    • Founded VMS Rehab Systems Inc in . Mr. Wexler has over years of knowhow and hands on management experience in the health industries. Negotiated the company s agreement as a core vendor of orthopedic seat cushions with Shoppers Drug Mart, Canada s largest home health and drug store retailer. More recently, Mr Wexler initiated an aggressive development and expansion program to broaden VMS market penetration in major global markets. An astute entrepreneur with over decades of hands on experience working with companies situated in North America and abroad, Mr. Wexler holds senior management positions and Board positions with companies in both the private and public sectors. An alumni of both Carleton University and the University of Ottawa, Mr. Wexler is a life member of the Rideau Club, Ottawa, Canada.

Current Share Structure

  • Market Cap: $522,038 - 03/09/2018
  • Issue and Outstanding: 47,457,980 - 10/25/2017
  • Float: 14,000,000 - 10/25/2017

 


Recent Filings from (OTC: VRSYF)

Interim Financial Report - VMS Q3 Financial Report
Filing Type: Interim Financial Report - VMS Q3 Financial ReportFiling Source: OTC Markets
Filing Date: December, 14 2017
Quarterly Report - Disclosure Document Q3 Sept 30th, 2017
Filing Type: Quarterly Report - Disclosure Document Q3 Sept 30th, 2017Filing Source: OTC Markets
Filing Date: December, 12 2017
Attorney Letter with Respect to Current Information - VRSYF Attorney Letter_Period Dec 31, 2016 to June 30th, 2017
Filing Type: Attorney Letter with Respect to Current Information - VRSYF Attorney Letter_Period Dec 31, 2016 to JFiling Source: OTC Markets
Filing Date: October, 26 2017
Quarterly Report - Disclosure Document June 30, 2017
Filing Type: Quarterly Report - Disclosure Document June 30, 2017Filing Source: OTC Markets
Filing Date: October, 23 2017
Annual Report - Disclosure Document Dec 31, 2016
Filing Type: Annual Report - Disclosure Document Dec 31, 2016Filing Source: OTC Markets
Filing Date: October, 23 2017
Quarterly Report - Disclosure Document Mar 31, 2017
Filing Type: Quarterly Report - Disclosure Document Mar 31, 2017Filing Source: OTC Markets
Filing Date: October, 23 2017
Officer/Director Disclosure - VRSYF June 30, 2017 OTC Disclosure Document
Filing Type: Officer/Director Disclosure - VRSYF June 30, 2017 OTC Disclosure DocumentFiling Source: OTC Markets
Filing Date: October, 18 2017
Officer/Director Disclosure - VRSYF March 31, 2017 OTC Disclosure Document
Filing Type: Officer/Director Disclosure - VRSYF March 31, 2017 OTC Disclosure DocumentFiling Source: OTC Markets
Filing Date: October, 18 2017
Officer/Director Disclosure - VRSYF Dec 31, 2016 OTC Disclosure Document
Filing Type: Officer/Director Disclosure - VRSYF Dec 31, 2016 OTC Disclosure DocumentFiling Source: OTC Markets
Filing Date: October, 18 2017
Interim Financial Report - Interim Financial Statement for the period ended June 30th, 2017.
Filing Type: Interim Financial Report - Interim Financial Statement for the period ended June 30th, 2017.Filing Source: OTC Markets
Filing Date: August, 21 2017

 

 


Daily Technical Chart for (OTC: VRSYF)

Daily Technical Chart for (OTC: VRSYF)


Stay tuned for daily updates and more on (OTC: VRSYF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: VRSYF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in VRSYF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of VRSYF and does not buy, sell, or trade any shares of VRSYF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/